A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.
Saved in:
| Title: | A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study. |
|---|---|
| Authors: | Kauffman TL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., O'Donnell EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Marinac CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adams K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Beckwith JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Berman TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Brantley KD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chowdhury D; Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Crompton BD; Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts., Diller LR; Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Elias KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Feltmate CM; Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts., Florez N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Ghobrial I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hormoz S; Harvard Medical School, Boston, Massachusetts.; Department of Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kamihara J; Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., LeBoeuf NR; Harvard Medical School, Boston, Massachusetts.; Department of Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mittendorf EA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rodriguez NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts., Sands J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Thapa B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Weeks LD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Woo SB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts., Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Parmigiani G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Rebbeck TR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Syngal S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. |
| Source: | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2026 Jul 01; Vol. 35 (7), pp. 1076-1087. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
